Elsevier

Human Pathology

Volume 27, Issue 12, December 1996, Pages 1324-1328
Human Pathology

Original contribution
Expression of cyclin D1 and c-Ki-ras gene product in human epithelial ovarian tumors

https://doi.org/10.1016/S0046-8177(96)90345-7Get rights and content

Abstract

The expression of cyclin Dl gene product in human ovarian tumors was studied. We found that cyclin D1 is expressed at high levels in several ovarian cancer cell lines. Immunohistochemical study also showed that a significant proportion of primary ovarian tumor tissues overexpressed cyclin D1 gene product. Clear nuclear staining of cyclin Dl protein was detected in 28% of the cases. We also characterized the expression of c-Ki-ras gene product in ovarian cancer cell lines and tumor tissues. Amplification or overexpression of this protooncogene has been reported in ovarian tumors from Taiwan. These results show that c-Ki-ras is strongly expressed in PA-1 and NIH: OVCAR-3 cells in which cyclin D1 also expressed at high levels. Specific cytoplasmic staining of c-Ki-ras protein was detected in 11 tumors (52%). Statistical analyses show a strong positive correlation between cyclin D1 and c-Ki-ras immunoexpression. Thus, these data support the ideas that cyclin D1 may be involved in the pathogenesis of ovarian cancer, and coactivation of cyclin D1 and c-Ki-ras gene expression may represent one of the major pathways that lead to the development of ovarian cancer in Taiwan.

References (29)

  • SCH Mok et al.

    Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy

    Cancer Res

    (1993)
  • EM Boltz et al.

    Amplification of c-Ki-ras oncogene in human ovarian tumors

    Int J Cancer

    (1989)
  • LJ van't Veer et al.

    Ras oncogene activation in human ovarian cancinoma

    Oncogene

    (1988)
  • MG Teneriello et al.

    p53 and Ki-ras Gene mutations in epithelial ovarian neoplasms

    Cancer Res

    (1993)
  • Cited by (48)

    • In vitro antiproliferative activity of 2,3-dihydroxy-9,10-anthraquinone induced apoptosis against COLO320 cells through cytochrome c release caspase mediated pathway with PI3K/AKT and COX-2 inhibition

      2016, Chemico-Biological Interactions
      Citation Excerpt :

      It is expressed in the G1 phase of the cell cycle, and is thought to regulate the G1/S transition point of the cell cycle by acting in conjunction with cyclin dependent kinase CDK4 [56,57]. The cyclins D1 and D2 have been reported to be over expressed in a variety of human cancers and chemical carcinogen induced mouse tumors [23,58–66]. The over expression of Cyclin D1 and D2 is common in cancer and is usually a result of defective regulation at the post translational level [23].

    • Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer

      2009, Critical Reviews in Oncology/Hematology
      Citation Excerpt :

      The predictive and prognostic relevance of different cell cycle- or apoptosis-regulatory proteins has been recently assessed in patients with EOC. Cyclin D1 is overexpressed in 18–89% of tissue sections from EOC, without any relationship with a specific histological type [84,95–102] (Table 3(a)). Some authors failed to detect an association between cyclin D1 expression and clinical outcome [97,98].

    • AKAP12 induces apoptotic cell death in human fibrosarcoma cells by regulating CDKI-cyclin D1 and caspase-3 activity

      2007, Cancer Letters
      Citation Excerpt :

      In general, uncontrolled CDK kinase activity is one of the major causes of cancer progression as their functions are tightly regulated by CDKIs proteins in normal cell cycle progression [19]. Also, the expression level of cyclin D1 is necessary for progression through G1 phase, and data from experimental and human cancers implicate cyclin D1 as a mediator of ras-induced proliferation [20]. In parallel with these reports, AKAP12 decreased cyclin D1 expression and increased CDKIs such as Cip1/p21 and Kip1/p27 which bind to cyclin-CDK complexes to inhibit their catalytic activity and induce cell cycle arrest in HT1080 cells.

    • Overexpression of cyclo-oxygenase 2 in squamous cell carcinoma of the hypopharynx

      2002, Human Pathology
      Citation Excerpt :

      Tumor tissues were classified as overexpression of protein if the signal intensity of tumor tissues was 2-fold higher than the average signal intensity of 4 adjacent oral mucosa obtained from patients. Immunohistochemical staining was performed as described previously.20 In brief, 5-μ m frozen sections were fixed with aceton and treated with 0.5% hydrogen peroxide to remove endogenous peroxidase activity.

    • Expression of cell cycle regulators p57<sup>KIP2</sup>, cyclin D1, and cyclin E in epithelial ovarian tumors and survival

      2001, Human Pathology
      Citation Excerpt :

      Thus, of the 3 ckis studied to date in epithelial ovarian cancer, only p27KIP1 has demonstrated a significant association with patient survival.4,7,10 Several studies have assessed epithelial ovarian tumors for overexpression of cyclin D1 using different methods, including immunohistochemistry and Northern and Western blot analysis, with reported incidences ranging from 10% to 32%.13-18 In our immunohistochemical study, we found nuclear accumulation of cyclin D1 in 13% of epithelial ovarian tumors.

    View all citing articles on Scopus

    Supported by the grant no. NSC 83-0412-B037-002 from the National Science Council, Republic of China.

    View full text